6KV3 image
Deposition Date 2019-09-03
Release Date 2020-09-09
Last Version Date 2023-11-22
Entry Detail
PDB ID:
6KV3
Keywords:
Title:
Crystal Structure of NAD+ Synthetase from Staphylococcus aureus
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:NH(3)-dependent NAD(+) synthetase
Gene (Uniprot):nadE
Chain IDs:A, B (auth: C), C (auth: B), D
Chain Length:281
Number of Molecules:4
Biological Source:Staphylococcus aureus (strain COL)
Primary Citation
Crystallographic and molecular dynamics simulation analysis of NAD synthetase from methicillin resistant Staphylococcus aureus (MRSA).
Int.J.Biol.Macromol. 165 2349 2362 (2020)
PMID: 33098904 DOI: 10.1016/j.ijbiomac.2020.10.096

Abstact

NAD synthetase (NadE) catalyzes the last step in NAD biosynthesis, transforming deamido-NAD+ into NAD+ by a two-step reaction with co-substrates ATP and amide donor ammonia. In this study, we report the crystal structure of Staphylococcus aureus NAD synthetase enzyme (saNadE) at 2.3 Å resolution. We used this structure to perform molecular dynamics simulations of apo-enzyme, enzyme-substrate (NadE with ATP and NaAD) and enzyme-intermediate complexes (NadE with NaAD-AMP) to investigate key binding interactions and explore the conformational transitions and flexibility of the binding pocket. Our results show large shift of N-terminal region in substrate bound form which is important for ATP binding. Substrates drive the correlated movement of loop regions surrounding it as well as some regions distal to the active site and stabilize them at complex state. Principal component analysis of atomic projections distinguish feasible trajectories to delineate distinct motions in enzyme-substrate to enzyme-intermediate states. Our results suggest mixed binding involving dominant induced fit and conformational selection. MD simulation extracted ensembles of NadE could potentially be utilized for in silico screening and structure based design of more effective Methicillin Resistant Staphylococcus aureus (MRSA) inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures